Your browser doesn't support javascript.
loading
Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection.
Jiang, Xiao-Lin; Zhu, Ka-Li; Wang, Xue-Jun; Wang, Guo-Lin; Li, Yi-Ke; He, Xue-Juan; Sun, Wen-Kui; Huang, Peng-Xiang; Zhang, Jin-Zhong; Gao, Hui-Xia; Dai, Er-Hei; Ma, Mai-Juan.
Afiliação
  • Jiang XL; Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention, Jinan, China.
  • Zhu KL; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China; Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China.
  • Wang XJ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China; Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, China.
  • Wang GL; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.
  • Li YK; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China; Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, China.
  • He XJ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China; Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, China.
  • Sun WK; Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention, Jinan, China.
  • Huang PX; Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention, Jinan, China.
  • Zhang JZ; Department of Infectious Disease Control and Prevention, Liaocheng Center for Disease Control and Prevention, Liaocheng, China.
  • Gao HX; Department of Laboratory Medicine, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, China.
  • Dai EH; Department of Laboratory Medicine, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, China.
  • Ma MJ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China; Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China; Department of Epidemiology, School of Public Health, Zhengzhou U
Lancet Infect Dis ; 23(1): 28-30, 2023 01.
Article em En | MEDLINE | ID: mdl-36543471
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Irruptivas / Anticorpos Antivirais Limite: Humans Idioma: En Revista: Lancet Infect Dis Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Irruptivas / Anticorpos Antivirais Limite: Humans Idioma: En Revista: Lancet Infect Dis Ano de publicação: 2023 Tipo de documento: Article